A randomized phase 1 single-dose polysomnography study of ASP8062, a GABA B receptor positive allosteric modulator

ConclusionsSingle-dose ASP8062 (35 and 70  mg) appeared to result in CNS penetration and enhanced GABAergic activity as measured by increases in slow-wave sleep and growth hormone release.
Source: Psychopharmacology - Category: Psychiatry Source Type: research